Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term effects of irbesartan and atenolol on the renin-angiotensin-aldosterone system in human primary hypertension: the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Malmqvist K, Ohman KP, Lind L, Nyström F, Kahan T. Malmqvist K, et al. Among authors: nystrom f. J Cardiovasc Pharmacol. 2003 Dec;42(6):719-26. doi: 10.1097/00005344-200312000-00005. J Cardiovasc Pharmacol. 2003. PMID: 14639093 Clinical Trial.
Regression of left ventricular hypertrophy in human hypertension with irbesartan.
Malmqvist K, Kahan T, Edner M, Held C, Hägg A, Lind L, Müller-Brunotte R, Nyström F, Ohman KP, Osbakken MD, Ostergern J. Malmqvist K, et al. Among authors: nystrom f. J Hypertens. 2001 Jun;19(6):1167-76. doi: 10.1097/00004872-200106000-00023. J Hypertens. 2001. PMID: 11403367 Clinical Trial.
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.
Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman KP, Nyström F, Hägg A, Lind L; Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) Trial. Kurland L, et al. Among authors: nystrom f. J Hypertens. 2001 Oct;19(10):1783-7. doi: 10.1097/00004872-200110000-00012. J Hypertens. 2001. PMID: 11593098 Clinical Trial.
Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman P, Nyström F, Hägg A, Lind L. Kurland L, et al. Among authors: nystrom f. J Hypertens. 2002 Apr;20(4):657-63. doi: 10.1097/00004872-200204000-00023. J Hypertens. 2002. PMID: 11910301 Clinical Trial.
175 results